RapidAI receives FDA clearance for Rapid RV/LV

2021 03 17 23 48 7787 Computer Ai Hud Display 400

Artificial intelligence (AI) software developer RapidAI has secured U.S. Food and Drug Administration (FDA) 510(k) clearance for its Rapid RV/LV software.

Available as part of the firm's Rapid PE detection and analysis software for suspected cases of pulmonary embolism (PE), the RV/LV software automatically calculates an important indicator of PE severity -- the ratio between the right and left ventricles -- on CT pulmonary angiograms, RapidAI said. Results are available within minutes, enabling care teams to more quickly prioritize patients and speed up decision-making, according to the vendor.

Page 1 of 650
Next Page